1. Amgen buying drug discovery biotech Nuevolution for $167M — Novartis’ asthma drug beats GSK’s Advair in trial — Lilly’s mirikizumab succeeds in phase 2 Crohn’s trial -- See more on our front page news

    Got questions about whistleblowing?: Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

2019 Oncology Reorg

Discussion in 'Merck' started by anonymous, May 9, 2019 at 6:00 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    609 reps? PC drumbeat goes on. Hocus Pocus
     
  2. anonymous

    anonymous Guest

    Why does Merck think adding more reps is helpful??? They hurt everyones access
     
  3. anonymous

    anonymous Guest

    What is the salary for these positions and what type of experience is needed.
     
  4. anonymous

    anonymous Guest

    Minimum wage, no experience needed, HS education or GED
     
  5. anonymous

    anonymous Guest

    what a bunch of mindless drones...just keep adding more and more reps....just makes access worse and the pod mentality is totally outdated and a waste of $$$.
     
  6. anonymous

    anonymous Guest

    Primary care experience preferred, as no currently employed external oncology rep will want to be one of 7 per territory with new idiot structure. Those that still have decent access won’t much longer come October 1.
     
  7. anonymous

    anonymous Guest

    Merck doesn't want to pay for external experience. It's easier for them to promote an internal specialty or primary care rep and get them on the cheap.